Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Department of Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.
J Alzheimers Dis. 2019;68(2):551-558. doi: 10.3233/JAD-181108.
For early-onset Alzheimer's disease (EOAD) cases with unclear family history, most cases are sporadic. Some cases are positive in genetic findings, that is, either incomplete penetrance or de novo mutation. We aimed to focus on EOAD cases with de novo mutations. Case reports and literature review were performed. The implication for diagnostic approach of early-onset dementia with negative family history was developed. We reported two Chinese EOAD cases with de novo mutations. The genotype PSEN1 G206S appeared to correlate with the phenotype of EOAD with pure cognitive problems. The second case had a PSEN1 M233V mutation with an earlier age of onset of 25 with cognitive decline, parkinsonism, and epilepsy. Although EOAD due to de novo mutations is not common, it should be considered in patients with a phenotype of progressive cognitive decline and amyloid positivity on PET or CSF analysis.
对于家族史不明确的早发性阿尔茨海默病 (EOAD) 病例,大多数为散发性病例。部分病例在遗传发现中呈阳性,即不完全外显或新生突变。我们旨在关注具有新生突变的 EOAD 病例。进行了病例报告和文献复习。制定了针对无家族史早发性痴呆症的诊断方法的意义。我们报告了两例中国 EOAD 具有新生突变的病例。基因型 PSEN1 G206S 似乎与单纯认知问题的 EOAD 表型相关。第二例为 PSEN1 M233V 突变,发病年龄较早,为 25 岁,认知功能下降,伴帕金森病和癫痫。尽管由于新生突变引起的 EOAD 并不常见,但在 PET 或 CSF 分析显示淀粉样蛋白阳性且出现进行性认知功能下降的患者中应考虑这种情况。